Santa Cruz Biopharm Firm Tosk, Inc. Looks to Raise $5.1 Million
Published: Dec 29, 2011
Tosk Inc. has raised $798,000 of a proposed $5.1 million, according to a regulatory filing with the U.S. Securities and Exchange Commission on Friday.
The Santa Cruz-based biopharmaceutical company is developing drugs for debilitating and life-threatening diseases such as cancer, arthritis and Crohn's disease. It sold equity to raise the funds.